A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC
Clinical trial NCT06598046 · RECRUITING
Trial details
- NCT number
- NCT06598046
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2026-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.